Gene: LRRC37B
Official Full Name: leucine rich repeat containing 37Bprovided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30781 | LRRC37B Knockout cell line (HeLa) | Human | LRRC37B | 1:3~1:6 | Negative | Online Inquiry |
KO30782 | LRRC37B Knockout cell line (HCT 116) | Human | LRRC37B | 1:2~1:4 | Negative | Online Inquiry |
KO30783 | LRRC37B Knockout cell line (HEK293) | Human | LRRC37B | 1:3~1:6 | Negative | Online Inquiry |
KO30784 | LRRC37B Knockout cell line (A549) | Human | LRRC37B | 1:3~1:4 | Negative | Online Inquiry |
LRRC37B Gene Knockout Cell Lines are a powerful biological tool designed for studying the functional roles of the LRRC37B gene, which encodes a leucine-rich repeat protein implicated in various cellular processes. These genetically modified cell lines have been engineered to feature a complete knockout of the LRRC37B gene, enabling researchers to investigate the gene's contributions to cellular behavior, signaling pathways, and disease mechanisms without the influence of its product.
One of the key mechanisms through which these knockout cell lines operate is the loss of specific protein interactions and functions typically mediated by LRRC37B. This absence allows for the elucidation of phenotypic changes and molecular pathways that may be affected in its absence. Moreover, researchers can employ these cell lines to mimic conditions of gene loss associated with certain diseases, providing a relevant model for drug screening and therapeutic development.
Scientifically, the LRRC37B Gene Knockout Cell Lines have significant applications in both fundamental research and clinical settings, particularly in studies related to cancer biology, neurodegenerative diseases, and other disorders where LRRC37B may play a crucial role. By utilizing these cell lines, scientists can uncover new insights into gene function, interactions, and potentially identify novel therapeutic targets.
Compared to conventional wild-type cell lines, these knockout models offer distinct advantages: they facilitate clearer experimental interpretations due to reduced background noise from unwanted gene activity and provide a streamlined approach to studying gene function in vivo. The specificity of this gene alteration enables targeted insights that alternative products may lack, making them invaluable for researchers aiming for precision in their experimental designs.
For researchers, clinicians, and pharmaceutical developers, the ability to manipulate and understand gene function at a granular level presents unprecedented opportunities for advancing knowledge and therapeutics. Our company's expertise in biogenetics ensures the highest quality and reliability of these cell lines, supported by comprehensive technical documentation and customer assistance. When you choose LRRC37B Gene Knockout Cell Lines, you are investing in cutting-edge research potential backed by years of scientific innovation and commitment to excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.